Cone Lawrence A, Leung Millie M, Byrd Richard G, Annunziata Gary M, Lam Richard Y, Herman Brian K
Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
Surg Neurol. 2003 Apr;59(4):320-8. doi: 10.1016/s0090-3019(03)00056-9.
Central nervous system involvement often follows bacteremia because of Listeria monocytogenes. Meningitis is clinically the most common manifestation, while brain abscess occurs in about 1% of patients. Brain abscess is usually solitary but in recent years, probably in part because of the availability of computerized tomography and magnetic resonance imaging, several reports have described two or more separate supratentorial abscesses.
We have described three patients with listerial brain abscesses and reviewed the North American and European literature of brain abscess(es) because of L. monocytogenes through December 2001. We have evaluated the role of underlying diseases and therapeutic immunosuppression on the development of solitary or greater than one brain abscess.
In contrast to meningitis, where immunosuppression does not predispose either to disease incidence or to higher mortality, patients with solitary and particularly those with more than one supratentorial abscess usually are immunosuppressed either by disease or by therapy. Corticosteroids in particular are significant predisposing factors, especially in those patients with two or more brain abscesses. Mortality resulting from listerial brain abscess, whether solitary or multiple, is nearly three times higher than nonlisterial brain abscess, probably in part because of both underlying diseases and immunosuppressive therapy.
Therapy with high-dose ampicillin in combination with gentamicin appear to be the drugs of choice, followed by trimethoprim/sufamethoxazole and vancomycin. In general, antimicrobial therapy appears to be satisfactory treatment without surgical intervention.
因单核细胞增生李斯特菌引起的菌血症常继发中枢神经系统受累。脑膜炎是临床上最常见的表现,而脑脓肿约见于1%的患者。脑脓肿通常为单发,但近年来,可能部分由于计算机断层扫描和磁共振成像的应用,有几篇报告描述了两个或更多个独立的幕上脓肿。
我们描述了3例李斯特菌性脑脓肿患者,并回顾了截至2001年12月北美和欧洲有关单核细胞增生李斯特菌所致脑脓肿的文献。我们评估了基础疾病和治疗性免疫抑制在单发或多发脑脓肿发生中的作用。
与脑膜炎不同,免疫抑制既不增加脑膜炎的发病率,也不导致更高的死亡率,单发尤其是多发幕上脓肿的患者通常因疾病或治疗而处于免疫抑制状态。特别是皮质类固醇是重要的易感因素,尤其是在那些有两个或更多脑脓肿的患者中。无论是单发还是多发,李斯特菌性脑脓肿导致的死亡率几乎是非李斯特菌性脑脓肿的三倍,这可能部分归因于基础疾病和免疫抑制治疗。
大剂量氨苄西林联合庆大霉素治疗似乎是首选药物,其次是甲氧苄啶/磺胺甲恶唑和万古霉素。一般来说,抗菌治疗似乎是无需手术干预的满意治疗方法。